Related Experiment Video
Updated: Jul 28, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Rifampicin Allergy Leading to Acute Renal Shutdown
Ranjith Jeyasekharan1, Ninoo George2
1Department of General Medicine, Dr. Jeyasekharan Hospital and Nursing Home, Nagercoil, Tamil Nadu, India.
Abstract:
Rifampicin is a widely used drug to treat tuberculosis and leprosy. Its toxicity is predominantly hepatic and immunoallergic in character. While hepatic toxicity is dose-related, the immunoallergic effects are unpredictable and usually associated with intermittent therapy. These immunoallergic effects may be minor (a cutaneous, gastrointestinal, or influenza-like syndrome) or major (hemolytic anemia, shock, or acute renal failure). Herein, we report a case of rifampicin allergy in a patient who was on intermittent once monthly rifampicin therapy for neuritic leprosy and was on his 4th month of treatment. Rifampicin exposure led to sudden shock and acute renal failure, which eventually required hemodialysis support. The patient made a complete recovery over the subsequent days and his renal function returned to normal over the next 3 weeks. He continues his multidrug therapy of leprosy without rifampicin.
Insights
Rifampicin allergy can cause severe reactions like shock and acute renal failure, even with intermittent leprosy treatment. Prompt medical care led to full recovery, highlighting the need for careful monitoring.
Area of Science:
- Pharmacology
- Clinical Toxicology
- Infectious Disease Treatment
Background:
- Rifampicin is a cornerstone medication for tuberculosis and leprosy.
- Drug toxicity manifests as hepatic (dose-related) or immunoallergic (unpredictable) effects.
- Immunoallergic reactions range from mild syndromes to severe, life-threatening events.
Observation:
- A patient receiving intermittent, once-monthly rifampicin for neuritic leprosy developed sudden shock and acute renal failure.
- The severe reaction occurred during the 4th month of treatment.
- Hemodialysis was required to manage the acute renal failure.
Findings:
- The patient experienced a severe immunoallergic reaction to rifampicin.
- Renal function normalized within 3 weeks after treatment cessation.
- Complete recovery was achieved without further rifampicin exposure.
Implications:
- Intermittent rifampicin therapy, though common, carries a risk of unpredictable severe immunoallergic reactions.
- Early recognition and management of rifampicin-induced shock and renal failure are crucial for patient outcomes.
- Alternative treatment regimens may be necessary for patients experiencing such adverse events.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury I: Introduction
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Drug Excretion: Tubular Secretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Desensitization and Tachyphylaxis

